 Cohorts of 3-6 patients receive escalating doses of pixantrone until the maximum tolerated dose MTD is determined. The MTD is defined as the dose at which no more than 2 of 6 patients experience dose-limiting toxicity. Additional patients are treated at the recommended dose, which is defined as the dose preceding the MTD. 